Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis-Reference-Cited by-同舟云学术

Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis

Published:2024-09-13 Issue:1 Volume:15 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Bamezai Sharika,Zhang Yapei,Kumari Manisha,Lotfi Mozhgan,Alsaigh Tom^ORCID,Luo Lingfeng^ORCID,Kumar Gayatri Suresh^ORCID,Wang Fudi,Ye Jianqin^ORCID,Puri Madhu,Manchanda Romila,Paluri Sesha,Adkar Shaunak S.,Kojima Yoko,Ingelsson Alice,Bell Caitlin F.^ORCID,Lopez Nicolas G.,Fu Changhao,Choi Ryan B.^ORCID,Miller Zach,Barrios Leo,Walsh Susan,Ahmad Ferhaan,Maegdefessel Lars^ORCID,Smith Bryan Ronain^ORCID,Leeper Nicholas J.^ORCID

Funder

Falk Foundation

American Heart Association

Foundation for the National Institutes of Health

Greathouse Family Foundation

Sarnoff Cardiovascular Research Foundation

Perkin-Elmer Post-doctoral Fellowship

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41467-024-52005-1.pdf

Reference45 articles.

1. Arnett D. K. et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 74, 1376–1414 (2019).

2. Tsao C. W. et al. Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association. Circulation 145, e153-e639 (2022).

3. Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119–1131 (2017).

4. Adkar, S. S. & Leeper, N. J. Efferocytosis in atherosclerosis. Nat. Rev. Cardiol. https://doi.org/10.1038/s41569-024-01037-7 (2024)

5. Arandjelovic, S. & Ravichandran, K. S. Phagocytosis of apoptotic cells in homeostasis. Nat. Immunol. 16, 907–917 (2015).